SEC Filing Analysis: Performant Healthcare Inc (PHLT)

Executive Summary

• Trading Significance: Medium
• Key Takeaway: A director's entire holdings, valued at over $816,000, were disposed of as a mandatory action resulting from the company's acquisition.
• Market Impact: This filing codifies the final disposition of insider shares related to the merger. It is a procedural event and not indicative of negative insider sentiment.

Company Information

Field	Value
Company	Performant Healthcare Inc
Ticker Symbol	PHLT
CIK	0001550695
Industry	SERVICES-MISCELLANEOUS BUSINESS SERVICES

Insider Information

Field	Value
Name	Agrawal Shantanu
CIK	0002014640
Title/Position	null
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-21
Transaction Code	D
Security Type	Common Stock and Restricted Stock Units
Shares Involved	105,297
Price Per Share	$7.75
Total Value	$816,051.75
Shares Owned After	0
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$816,051.75
% of Market Cap	0.13%
Shares Transacted	105,297
% of Shares Outstanding	0.13%
Post-Transaction Ownership	0 shares (0.00% of outstanding)
Materiality Assessment	Moderate

Impact Evaluation

• Market Cap Context: For a company with a $610 million market cap, this $816k transaction is moderately sized, representing just 0.13% of the company's value.
• Ownership Concentration: The transaction liquidates the director's entire position, reducing their ownership from 105,297 shares to zero as part of the merger.
• Dilution Impact: Not applicable, as this is a disposition of existing shares and equity awards, not an issuance.
• Transaction Significance: The significance is moderate. While the complete exit of an insider is typically a strong signal, the context of a company-wide acquisition makes this a non-discretionary, procedural event affecting all shareholders. The value and share count are not large enough relative to the company's size to be considered highly significant on their own.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: This filing confirms a previously announced merger event. The transaction is a result of the acquisition, not a discretionary decision by the insider. It provides no new information that would influence the market's view of the company's standalone prospects.

Volume & Sentiment

• Expected Volume Impact: Minimal. The market has already priced in the acquisition.
• Sentiment Indicator: Neutral. This is a procedural filing related to a corporate action, not a reflection of insider sentiment.

Investment Insights

Positive Market Indicators

• The filing confirms the execution of the merger agreement, providing certainty to the event.

Risk Factors

• The insider no longer has any equity stake in the surviving entity, which is standard in a cash acquisition.

Key Takeaways

1. Merger-Driven Disposition: This is not an open-market sale. The transaction is a mandatory cash-out of all shares and RSUs due to the merger of Performant Healthcare with a subsidiary of Continental Buyer, Inc.
2. Fixed Price Transaction: All equity was converted to cash at a fixed price of $7.75 per share, as stipulated in the merger agreement.
3. Complete Exit: The director, Shantanu Agrawal, now holds zero shares in the company, which is the expected outcome of the acquisition for all shareholders.

Additional Context

Special Circumstances

• As detailed in footnotes F1, F2, and F3, the transaction is pursuant to the Agreement and Plan of Merger dated July 31, 2025. All outstanding Common Stock and unvested RSUs were canceled and converted into the right to receive the merger consideration of $7.75 in cash.